27 related articles for article (PubMed ID: 38755031)
1. Decreased
Giri PS; Bharti AH; Dwivedi M
J Immunol Res; 2022; 2022():3426717. PubMed ID: 36157881
[TBL] [Abstract][Full Text] [Related]
2. Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells' suppressive capacity in generalized vitiligo.
Giri PS; Bharti AH; Kode J; Begum R; Dwivedi M
Int Immunopharmacol; 2023 Dec; 125(Pt B):111174. PubMed ID: 37951194
[TBL] [Abstract][Full Text] [Related]
3. Altered regulatory T cell-mediated Natural Killer cells suppression may lead to generalized vitiligo.
Giri PS; Patel SS; Dwivedi M
Hum Immunol; 2024 Jan; 85(1):110737. PubMed ID: 38057201
[TBL] [Abstract][Full Text] [Related]
4. Calcium controlled NFATc1 activation enhances suppressive capacity of regulatory T cells isolated from generalized vitiligo patients.
Giri PS; Bharti AH; Begum R; Dwivedi M
Immunology; 2022 Nov; 167(3):314-327. PubMed ID: 35754117
[TBL] [Abstract][Full Text] [Related]
5. Genetic association of nuclear factor of activated T cells' 3'UTR and structural polymorphisms with susceptibility to generalized vitiligo in Gujarat population.
Giri P; Bhimani R; Patil S; Dwivedi M
Gene; 2023 Sep; 880():147629. PubMed ID: 37429370
[TBL] [Abstract][Full Text] [Related]
6. Implication of regulatory T cells' telomere shortening in pathogenesis of generalized vitiligo.
Giri P; Thakor F; Dwivedi M
Hum Immunol; 2024 May; ():110812. PubMed ID: 38755031
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Alterations in Regulatory T Cells' Frequency and Suppressive Capacity in Patients with Vitiligo.
Giri PS; Mistry J; Dwivedi M
J Immunol Res; 2022; 2022():6952299. PubMed ID: 36164321
[TBL] [Abstract][Full Text] [Related]
8. The role of regulatory T cells in vitiligo and therapeutic advances: a mini-review.
Jin S; Wan S; Xiong R; Li Y; Dong T; Guan C
Inflamm Res; 2024 Jun; ():. PubMed ID: 38839628
[TBL] [Abstract][Full Text] [Related]
9. Recent progress in the genetics of generalized vitiligo.
Spritz RA
J Genet Genomics; 2011 Jul; 38(7):271-8. PubMed ID: 21777851
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.
Dwivedi M; Kemp EH; Laddha NC; Mansuri MS; Weetman AP; Begum R
Autoimmun Rev; 2015 Jan; 14(1):49-56. PubMed ID: 25308528
[TBL] [Abstract][Full Text] [Related]
11. Replenishing Regulatory T Cells to Halt Depigmentation in Vitiligo.
Le Poole IC; Mehrotra S
J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S38-S45. PubMed ID: 28941492
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]